|
Originally published In Press as doi:10.1074/jbc.M005429200 on September 29, 2000
J. Biol. Chem., Vol. 275, Issue 52, 41074-41081, December 29, 2000
Thyroglobulin Is Selected as Luminal Protein Cargo for Apical
Transport via Detergent-resistant Membranes in Epithelial Cells*
Fernando
Martin-Belmonte §,
Miguel A.
Alonso ,
Xiaoqing
Zhang¶, and
Peter
Arvan¶
From the Centro de Biologia Molecular "Severo
Ochoa," Universidad Autonoma de Madrid, Madrid 280-49, Spain
and the ¶ Department of Developmental and Molecular Biology,
and Division of Endocrinology, Albert Einstein College of
Medicine, Bronx, New York 10461
Received for publication, June 21, 2000, and in revised form, September 25, 2000
 |
ABSTRACT |
Thyroid hormone synthesis by thyrocytes depends
upon apical secretion of thyroglobulin (Tg), the glycoprotein
prohormone. In stably transfected MDCK cells, recombinant Tg is also
secreted apically. All secreted Tg has undergone Golgi carbohydrate
modification, whereas most intracellular Tg (which is slow to exit the
endoplasmic reticulum) is sensitive to digestion with
endoglycosidase H. However, in MDCK cells and PC Cl3 thyrocytes, a
subpopulation of newly synthesized recombinant and endogenous Tg,
respectively, is recovered in a Triton X-100 insoluble,
glycosphingolipid/cholesterol-enriched (GEM/raft) fraction, and this
small subpopulation is overwhelmingly endoglycosidase H resistant. Upon
apical secretion, Tg solubility is restored. Apical secretion of Tg is
inhibited by cellular cholesterol depletion. In FRT cells, recombinant
Tg becomes Triton X-100 insoluble within 60 min after synthesis and a
portion is actually endoglycosidase H-sensitive, suggesting early Tg
entry into GEMs/rafts. Interestingly in FRT cells, Tg remains
associated with the apical plasma membrane upon exocytosis, and all
surface Tg is GEM/raft-associated. Thus, Tg is the first secretory
protein demonstrated to enter Triton X-100 insoluble membranes en route
to the apical surface of epithelial cells. The data imply that Tg
utilizes a cargo-selective mechanism for apical sorting.
 |
INTRODUCTION |
The functional unit of the thyroid gland is the thyroid follicle,
each follicle representing a simple epithelium in which a monolayer of
thyroid epithelial cells surrounds a central (apical) lumen (1).
Thyroglobulin (Tg),1 the
thyroid hormone precursor protein and predominant gene product of the
thyroid, is a large, homodimeric glycoprotein that is secreted overwhelmingly to the apical (luminal) side of thyrocytes (2). A
failure of Tg secretion is an established cause of hypothyroidism and
goiter (3). Nevertheless, aside from the protein folding steps that are
prerequisite for its ER-to-Golgi transport (4), the mechanism(s)
responsible for apical Tg trafficking remain undefined.
In thyrocytes, it is clear that not only is the
trans-Golgi network the site of polarized sorting of
surface membrane proteins (5), but it is also the site of segregation
of apically bound Tg away from basolaterally secreted proteins (such as
thrombospondin 1, laminin, or tissue-type plasminogen activator
(6-8)). Indeed, polarized sorting of secretory proteins shows
similarities between thyrocytes and MDCK cells (9). Because in both
cell types basolaterally as well as apically secreted proteins are
highly polarized rather than exhibiting random distributions, the
implication is that both basolateral (10) and apical secretory proteins
(11) may exhibit cargo-selective entry into trans-Golgi
network-derived export pathways (12). Although data supporting
cargo-selective carrier mechanisms for apical transport have been
presented for several model membrane proteins (13-15), thus far, no
data have been shown that demonstrate any specific class of membranes
or membrane binding sites for Golgi-derived apical secretory proteins. To understand apical Tg transport, including the possibility of luminal
cargo selectivity in the process, we need to better define the nature
of the apical pathways available for secretory proteins in simple
epithelial cells.
In epithelial cells lacking a conventional regulated secretory pathway,
one apical Golgi-to-surface transport pathway has been described for
influenza virus hemagglutinin and other apical membrane proteins, which
may involve segregation in detergent(Triton X-100)-insoluble
glycosphingolipid/cholesterol-enriched membranes (GEMs) (16), also
known as liquid-ordered domains (17) or rafts (18). The GEM/raft
pathway, which is sensitive to perturbations of cellular cholesterol
(18), has long been implicated in the surface delivery of
glycosylphosphatidylinositol-anchored proteins (19) and has been
speculated to serve as a route for apically secreted glycoproteins
(11). Actually, Triton X-100-insoluble GEMs/rafts have never yet
been shown to carry any apical secretory proteins. Indeed, both
gp80/clusterin (the major endogenous apical secretory glycoprotein of
MDCK cells) and a truncated, soluble form of placental alkaline
phosphatase (that is apically secreted from FRT cells) have both been
specifically investigated and not recovered in conventional Triton
X-100-insoluble GEM/raft fractions, although such proteins might
dissociate from components of GEM/raft microdomains upon
permeabilization with detergent (20, 21).
Another apical secretory pathway typically seen in exocrine cells
involves the regulated exocytosis of apical storage granules (22); in
such cells this route might conceivably subserve a role in biogenesis
of the apical plasma membrane (23, 24). Regulated apical secretion is
particularly relevant to thyrocytes, which have an exocrine
organization and an acute thyrotropin-stimulated exocytotic
response (2). Indeed, we have recently described two heterologously
regulated secretory proteins that can be secreted apically upon
transient expression in filter-grown primary thyrocytes. From this and
other studies, we have proposed important relationships between the
apical trafficking of Tg and its sorting into the regulated secretory
pathway (6, 9).
Recently, two differently regulated secretory protein markers,
prohormone convertase 2 and carboxypeptidase E, have been found to
associate with GEM/raft microdomains along the pathway of secretory granule biogenesis (25, 26). Thus, although additional mechanisms (16,
27-31) and additional trafficking routes (6, 32) may contribute to
apical protein secretion (33), and although Tg secreted from dispersed
thyroid cells is fully soluble in the presence or absence of cold
Triton X-100 (34, 35),2 we
have investigated the possibility that Tg might associate with
GEMs/rafts in the secretory pathway. We now report the targeting of
newly synthesized recombinant Tg to Triton X-100 insoluble microdomains
in MDCK and FRT cells, as well as endogenous Tg in PC Cl3 thyrocytes.
From these studies, we can report that Tg is the first secretory
protein positively identified to enter the GEM/raft pathway en route to
the apical surface of epithelial cells.
 |
EXPERIMENTAL PROCEDURES |
Materials--
The cDNA construct expressing bovine Tg was
described previously (36). Rabbit polyclonal antibodies to Tg and to
caveolin were obtained from Dr. P. R. Larsen (Brigham and Women's
Hospital, Boston, MA) and Transduction Laboratories (Lexington, KY),
respectively. The monoclonal antibodies against gp114 (37) or
dipeptidylpeptidase IV (38) were obtained from the laboratory of Dr. E. Rodriguez-Boulan (Cornell Medical School, New York, NY). A monoclonal
antibody to Golgi mannosidase II (originally made by Dr. B. Burke, U. of Calgary, Canada) was obtained from Dr. D. Shields, Albert Einstein College of Medicine). A monoclonal antibody against EEA1 was purchased from BC Transduction Laboratories (cat. No. E41120). Polyclonal rabbit antibodies against transferrin were from Dako (Carpinteria, CA;
cat. No. A0061) and were biotinylated; these antibodies were applied to
FRT cells that had been incubated with transferrin (1 mg/ml) for 30 min
at 37 °C before fixation. Peroxidase-conjugated secondary
anti-IgG antibodies,
sulfo-N-hydroxyl-succinimido-biotin (sulfo-NHS-biotin),
streptavidin-agarose, streptavidin-fluorescein isothiocyanate, and
streptavidin-peroxidase were from Pierce. Fluorescein- and Texas
Red-conjugated antibodies were from Southern Biotechnology (Birmingham,
AL). Compactin was obtained from Fluka Chemie AG (Buchs, Switzerland).
Triton X-100, methyl- -cyclodextrin (CD), mevalonate,
fumonisin B1 (FB1), transferrin, and octylglucoside were
purchased from Sigma.
Cell Culture and Transfection--
MDCK II cells were grown on
Petri dishes in Dulbecco's modified Eagle's medium supplemented with
10% fetal bovine serum (Life Technologies, Inc.), penicillin (50 units/ml), and streptomycin (50 mg/ml), at 37 °C in an atmosphere of
5% CO2. FRT and PC Cl3 cells were grown in F12 Coon's
medium (Sigma) plus 10% fetal bovine serum and antibiotics. In
the case of PC Cl3 cells, the culture medium was supplemented with 10 micro-units/ml thyrotropin, 1 µg/ml insulin, 5 µg/ml
transferrin, and 10 nM hydrocortisone.
MDCK II (2 × 105) cells were transfected with 1-2 µg of
plasmid DNA using lipofectAMINE (Life Technologies, Inc.). FRT cell transfections were carried out by electroporation. Beginning at 48 h after transfection, stable transformants were selected by treatment
with either 0.8 mg/ml (MDCK) or 0.5 mg/ml (FRT) G418 sulfate (Life
Technologies, Inc.) for at least 4 weeks following transfection.
Drug-resistant cells were selected and then screened either by
immunoblotting or immunofluorescence analysis. Positive MDCK clones
were routinely maintained in the presence of G418, whereas positive FRT
clones were maintained in drug-free medium. After several passages,
>95% of cells within selected positive clones retained expression of
Tg.
Detergent Extraction Procedures--
GEMs/rafts were isolated by
standard procedures (19). Cells grown to confluency in 100-mm dishes
were rinsed with phosphate-buffered saline (PBS) and lysed for 20 min
in 1 ml of 25 mM Tris-HCl, pH 7.5, 150 mM NaCl,
5 mM EDTA, and 1% Triton X-100 at 4 °C. The lysate was
scraped from the dishes with a cell lifter, the dishes rinsed with 1 ml
of the same buffer at 4 °C, and the lysate homogenized by passing
the sample through a 22-gauge needle. The extract was finally brought
to 40% sucrose in a final volume of 4 ml beneath an 8-ml 5-30%
linear sucrose gradient. Gradients were centrifuged for 18 h at
39,000 rpm at 4 °C in a Beckman SW41 rotor. Fractions of 1 ml were
harvested from the bottom of the tube, and aliquots were subjected to
immunoprecipitation or immunoblot analysis. For the experiment shown in
Fig. 5C, a discontinuous sucrose gradient was used. In this
protocol, the 40% sucrose load was overlaid with 6 ml of 30% sucrose
and 2 ml of 5% sucrose. After centrifugation, the opalescent band at
the 30-5% sucrose interface, containing GEMs/rafts, was collected as
the Triton X-100 insoluble fraction, whereas the 40% sucrose layer
containing the load was harvested as the Triton X-100 soluble fraction.
Immunoblotting and Immunoprecipitation--
For immunoblot
analysis, samples were subjected to SDS-15% PAGE under reducing
conditions and transferred to Immobilon-P membranes (Millipore,
Bedford, MA). After blocking with 5% (w/v) nonfat dry milk plus 0.05%
(v/v) Tween 20 in PBS, blots were incubated with the indicated primary
antibody. After several washings, blots were incubated for 1 h
with goat anti-mouse or anti-rat IgG antibodies coupled to horseradish
peroxidase, washed extensively, and developed using an enhanced
chemiluminescence Western blotting kit (ECL, Amersham Pharmacia Biotech).
For metabolic labeling, cells were starved in culture medium lacking
methionine and cysteine for 30 min and incubated with 100-500 µCi of
a [35S]methionine/cysteine mixture (ICN, Costa Mesa, CA)
for the indicated times at 37 °C. After labeling, the medium was
removed and replaced with complete culture medium. For
immunoprecipitation, antibodies were prebound overnight at 4 °C to
protein A-Sepharose in 10 mM Tris-HCl, pH 8.0, 0.15 M NaCl, 1% Triton X-100. Cell extracts were precleared for
4 h at 4 °C with a control antibody bound to protein
A-Sepharose, and the supernatant was immunoprecipitated by incubation
for 4 h at 4 °C with the appropriate antibodies bound to
protein A-Sepharose. After collection, the immunoprecipitates were
washed six times with 1 ml of 10 mM Tris-HCl, pH 8.0, 0.15 M NaCl, 1% Triton X-100 and analyzed by SDS-PAGE under
reducing conditions. To detect 35S labeling, dried gels
were finally exposed to Fujifilm imaging plates (Fuji Photo Film
Co.). For analysis of endoglycosidase H resistance,
immunoprecipitates were incubated overnight at 37 °C in the presence
or in the absence of 0.05 units/ml endoglycosidase H (Roche Molecular
Biochemicals) before analysis by SDS-PAGE. Precipitation with
streptavidin-agarose used a protocol similar to that described for
immunoprecipitation. Quantitative analyses were done using a computing densitometer.
Domain-selective Biotinylation--
For separate access to
apical or basolateral domains, FRT or MDCK cells were seeded at
confluent levels on 24-mm polyester tissue culture inserts of 0.4 mm
pore size (Transwell-Clear, Costar Inc., Cambridge, MA). The integrity
of the cell monolayer was monitored by measuring the transepithelial
electrical resistance using the Millicell ERS apparatus (Millipore
Corp.). For metabolic labeling of cells in filters, cells were starved
in media lacking methionine and cysteine. After 30 min, 250 µCi of
[35S]methionine/cysteine were added to the basolateral
compartment, and filters were incubated for 30 min at 37 °C. To
analyze polarized secretion of Tg, apical and basolateral culture media
were removed 4 h later and subjected to immunoprecipitation
analysis with anti-Tg antibodies.
For surface labeling, cells were washed with ice-cold PBS containing
0.1 mM CaCl2and 1 mM
MgCl2, and 0.5 mg/ml sulfo-NHS-biotin were added either to
the apical or basolateral compartment of the filter chamber. After 30 min at 4 °C, the solution was removed and the remaining unreacted
biotin quenched by incubation with ice-cold serum-free culture medium.
Cell monolayers were finally washed with PBS and extracted with 0.5 ml
of 25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 60 mM octylglucoside for 30 min on ice (except in Fig. 7C, where
octylglucoside was omitted). Tg was immunoprecipitated from the
extracts, which were then further analyzed either by blotting with
streptavidin-peroxidase or a by a second round of precipitation
with streptavidin-agarose.
Confocal Immunofluorescence--
MDCK and FRT cells grown on
tissue culture inserts were fixed in 4% formaldehyde for 15 min,
rinsed, and then quenched for 5 min with 10 mM glycine. The
cells were then permeabilized or not with 0.2% Triton X-100, rinsed,
and incubated with 3% bovine serum albumin in phosphate-buffered
saline for 15 min. Cells were then incubated for 1 h with the
indicated primary antibodies, rinsed several times, and incubated for
1 h with specific fluorescent secondary antibodies. Images were
obtained using a Bio-Rad Radiance 2000 confocal laser microscope.
Controls to assess the specificity of the labeling included incubations
with control antibodies or omission of primary antibodies.
 |
RESULTS |
In MDCK Cells and PC Cl3 Thyrocytes, Tg Is Secreted Apically and Is
Recovered in the GEM/Raft Fraction--
Because of its large size, a
full-length expressible Tg cDNA has become available only
relatively recently (36), and the secretory polarity of the recombinant
protein has never been examined. We therefore prepared stably
transfected MDCK cells expressing Tg and selected positively expressing
clones based on immunoblotting of conditioned media. Similar to
endogenous Tg in primary thyrocytes (39), recombinant Tg secretion from
MDCK cells appeared slow but efficient (exhibiting a
t1/2 of several hours; see below). Three clones were
analyzed in detail, but all clones exhibited the same Tg secretion
phenotype. After a pulse-chase with 35S-labeled amino
acids, by high resolution SDS-PAGE, intracellular Tg exhibited two very
closely spaced bands: a dark faster-migrating species and a faint
slower-migrating species (Fig.
1A). Previous studies have
established that these bands reflect the state of carbohydrate
processing and correspond to ER and Golgi/post-Golgi forms of Tg,
respectively (39). Importantly, as in thyrocytes (7), recombinant Tg
secreted from filter-polarized MDCK cells exhibited a marked apical
polarity (Fig. 1A). Notably, all recombinant Tg recovered
from the cell culture supernatant exhibited a mobility corresponding to
the slower migrating, post-Golgi species (Fig. 1A) and was
resistant to digestion with endoglycosidase H (Fig. 1B). By
contrast, the pool of endoglycosidase H-resistant intracellular Tg,
even at late chase times, was quite small (Fig. 1B), Thus, in MDCK cells as in CHO cells (36, 40), recombinant Tg transport from
Golgi to surface is a relatively rapid step so that the cells maintain
only a small intracellular Golgi/post-Golgi pool of Tg at any
moment.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 1.
Polarized secretion of Tg in MDCK cells.
Panel A, MDCK cells stably expressing recombinant
Tg, grown on filters, were metabolically labeled with
[35S]methionine/cysteine for 30 min. After a 4-h chase,
media were recovered from both the apical ("A") and
basolateral ("B") compartments and the cells were lysed
(Lys). Tg was then immunoprecipitated and analyzed by
SDS-PAGE and autoradiography. Note that Tg was secreted with apical
predominance. B, MDCK cells grown in plastic dishes were
labeled and chased as in panel A. The cell culture
supernatant (Sup) and cell lysate (Lysate) was
analyzed. After immunoprecipitation with anti-Tg, the samples were
resuspended in denaturing buffer, split in two, and incubated either in
the absence ( ) or presence (+) of endoglycosidase H (Endo
H). Note that secreted Tg was resistant (R), whereas
intracellular Tg was sensitive (S) to endoglycosidase H
digestion.
|
|
With this fact in mind, we proceeded to examine Tg solubility in
cold Triton X-100 as analyzed by a flotation sucrose gradient in which
proteins entering Triton X-100-insoluble lipid-enriched microdomains
(GEMs/rafts) selectively float out of the load, whereas other
Triton-insoluble proteins (such as cytoskeleton) or Triton-soluble proteins cannot float because of their higher buoyant density (19). As
shown in Fig. 2A, the vast
majority of intracellular Tg remained in the load fractions (1-4) at
the bottom of the gradient. From a sample of this material (fraction 2)
it was apparent that all of the load was composed of endoglycosidase
H-sensitive Tg (Fig. 2B, first two lanes). However, a small
portion of the total intracellular Tg was observed to float out of the
load, into fractions enriched in GEMs/rafts (fractions 7-9), as
indicated by the marker, VIP21/caveolin-1 (Fig. 2A). When a
sample of this material (from fraction 8) was analyzed, all detectable
Tg was endoglycosidase H-resistant (Fig. 2B, last two
lanes). These data suggest that in MDCK cells, recombinant Tg
enters the GEM/raft pathway on its way to the apical surface.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 2.
Incorporation of Tg into GEMs/rafts of MDCK
cells. A, MDCK cells expressing Tg were metabolically
labeled for 4 h with a mixture of
[35S]methionine/cysteine, extracted with 1% Triton X-100
at 4 °C, and centrifuged to equilibrium in a continuous sucrose
density gradient. Fractions of 1 ml were collected from the bottom of
the tube. Fractions 1-4 are the 40% sucrose layer and
contain the soluble material, whereas fractions 5-12 are
the lower density fractions that include GEMs/rafts. Tg
immunoprecipitated from each fraction was analyzed by SDS-PAGE and
autoradiography (top panel). As a control, the distribution
of VIP 21/caveolin on the gradient was analyzed by immunoblotting
(bottom panel). B, samples of Tg from the Triton
X-100-soluble and -insoluble (GEM/raft) fractions are sensitive
(S) and resistant (R) to endoglycosidase H
(Endo H) digestion, respectively. As indicated, Tg
immunoprecipitated from fractions 2 and 8 of the
gradient were analyzed by digestion in the absence ( ) or presence (+)
of endoglycosidase H.
|
|
The GEM/raft microdomain is known to be destabilized by cellular
cholesterol depletion (18), and in MDCK cells, this leads to impaired
apical delivery of proteins that use this pathway (41). We therefore
examined the effect of cholesterol depletion (by treating cells with
compactin/mevalonate plus methyl- -cyclodextrin) on Tg secretion from
MDCK cells. As a control, we also examined the secretion of endogenous
gp80/clusterin, in which apical polarity is known to be disrupted by
this treatment (41). Unlike untreated cells, which released a large
fraction of Tg to the apical medium after cholesterol depletion, apical
Tg secretion was profoundly inhibited (Fig.
3A). This behavior was
paralleled by inhibition of the apical secretion of gp80/clusterin
(Fig. 3B). These effects are quantitated in the
panels at the bottom of Fig. 3. By contrast, fumonisin B1 (FB1), an inhibitor of
glycosphingolipid synthesis, which was recently reported to impair
apical transport of placental alkaline phosphatase or chimeras thereof
(21), had no effect on apical Tg or gp80 secretion.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 3.
Apical secretion of Tg in MDCK cells is
sensitive to cholesterol depletion but not to FB1
treatment. MDCK cells grown in filter culture inserts were
pretreated or not with 25 mM compactin, 200 mM
mevalonate for 48 h or with FB1 (25 mg/ml) for 72 h. To increase the extent of cholesterol depletion, cultures pretreated
with compactin/mevalonate were then treated with 10 mM
methyl- -cyclodextrin (CD) for 1 h at 37 °C. After
these treatments, cells were metabolically labeled for 30 min with
[35S]methionine/cysteine and chased in serum-free medium
for 4 h at 37 °C. Chase media were collected from the apical
("A") and basolateral ("B") compartments.
Panel A, immunoprecipitation of secreted Tg. Panel
B, the same supernatants were precipitated with 10%
trichloroacetic acid and analyzed by SDS-PAGE and autoradiography to
detect gp80 without immunoprecipitation (because this is the major
endogenous secretory protein of MDCK cells). The panels
below, in A and B, show a quantitative
analysis of the gels above.
|
|
Next, we turned our attention to endogenous Tg expressed in PC Cl3
thyrocytes, in which secreted Tg (as in normal thyrocytes) is
predominantly apical (Fig. 4C)
and exclusively endoglycosidase H-resistant.2
Specifically, we examined the ability of newly synthesized Tg from PC
Cl3 cells to partition into the Triton X-100-insoluble GEM/raft
fraction, as analyzed by flotation sucrose gradient. The data shown in
Fig. 4A, similar to that in MDCK cells, indicate the
presence of a small population of newly synthesized Tg in the GEM/raft
fraction. Further analysis of a sample of this material (from fraction
8) showed that, as for recombinant Tg in MDCK cells, this subpopulation
of intracellular Tg was endoglycosidase H-resistant (Fig.
4B). Together, these data strongly suggest that in
thyrocytes as well as MDCK cells, Tg en route to the apical cell
surface enters GEM/raft microdomains.

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 4.
Incorporation of endogenous Tg into
GEMs/rafts in PC Cl3 thyrocytes. A, PC Cl3 cells were
metabolically labeled, extracted with 1% Triton X-100, and centrifuged
to equilibrium in a continuous sucrose density gradient as described in
the legend for Fig. 2A. Tg immunoprecipitated from each
fraction was analyzed by SDS-PAGE and autoradiography. At a slightly
longer exposure (not shown), labeled Tg was also detected in fraction
9. B, samples of Tg from the Triton X-100-soluble and
-insoluble (GEM/raft) fractions are sensitive (S) and
resistant (R) to endoglycosidase H (Endo H)
digestion, respectively. As indicated, Tg immunoprecipitated from
fractions 2 and 8 of the gradient, representative
of Triton X-100-soluble and -insoluble fractions, respectively, were
analyzed by digestion in the absence ( ) or presence (+) of
endoglycosidase H. C, PC Cl3 cells were grown on
Transwell-clear filters. Apical ("A") and basal
("B") media bathing cells labeled continuously for
4 h were analyzed by Tg immunoprecipitation, SDS-PAGE, and
fluorography.
|
|
In FRT Cells, Tg Enters the GEM/Raft Fraction and Is Delivered to
the Apical Plasma Membrane--
FRT cells have gained attention over
the past decade because, whereas the influenza hemagglutinin
transmembrane protein is sorted apically (42), luminally anchored
glycosylphosphatidylinositol (GPI)-linked proteins are preferentially
delivered to the basolateral surface of these cells, unlike in MDCK
cells (43). Apparently, this phenotype is not because GEMs/rafts fail
to function as apical carriers, but rather is due to an inability of
GPI-linked proteins to enter the Triton X-100 insoluble GEM/raft
fraction (44). Thus, it was of obvious relevance to determine whether
Tg could enter the GEM/raft pathway to the apical surface of FRT cells, especially since FRT cells are originally derived from thyroid cultures. However, FRT cells do not endogenously express any
thyroid-specific differentiation markers; therefore, the cells were
stably transfected with the Tg cDNA, and stable Tg-expressing
clones were selected.
After 4 h of continuous labeling with 35S-labeled
amino acids, Tg-expressing FRT cells were extracted with ice-cold
Triton X-100 and the extract analyzed by flotation during sucrose
gradient centrifugation (Fig.
5A). Although a significant
portion of labeled Tg was recovered in the load (fractions 1-4), a
major portion of Tg floated with GEMs/rafts (fractions 7-9). Once
again, a sampling of Tg from the load fraction was entirely
endoglycosidase H-sensitive, whereas Tg recovered from the GEM/raft
fraction was enriched ( 70%) in endoglycosidase H-resistant forms
(Fig. 5B). However, a smaller portion of Tg recovered in the
GEM/raft fraction ( 30%) was noted to be endoglycosidase H-sensitive
(Fig. 5B). Recently, it has been suggested that association
of exocytic proteins with the GEM/raft microdomain may start taking
place shortly after their biosynthesis, increasing during transport
along the secretory pathway (45). With this in mind, we performed
pulse-chase experiments to look at the development of Triton X-100
insolubility in FRT cells. Within 60 min after a 30 min pulse-labeling
of FRT cells, more than half of the newly synthesized Tg had become
Triton X-100-insoluble (Fig. 5C), although a significant
portion of this material was endoglycosidase H-sensitive (Fig.
5D); whereas at the end of the chase, all Triton
X-100-insoluble Tg was endoglycosidase H-resistant (Fig.
5D). Thus, in the steady state, Triton X-100-insoluble Tg appears to be largely endoglycosidase H-resistant; however, the data
suggest that at least a portion of newly synthesized Tg is likely to
associate with GEMs/rafts even before its arrival in the medial Golgi
compartment.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 5.
Tg rapidly enters the GEM/raft fraction of
FRT cells. A, FRT cells stably expressing Tg were
metabolically labeled, extracted with 1% Triton X-100, and centrifuged
to equilibrium in a continuous sucrose density gradient as described in
the legend for Fig. 2A. Tg immunoprecipitated from each
fraction was analyzed by SDS-PAGE and autoradiography. B, as
indicated, Tg immunoprecipitated from fractions 2 and
8 from the gradient, representative of Triton X-100-soluble
and -insoluble (GEM/raft) fractions, respectively, were analyzed by
digestion in the absence ( ) or presence (+) of endoglycosidase H
(Endo H). C, FRT cells were pulse-labeled for 30 min with [35S]methionine/cysteine and chased for the
times indicated. Cells were then extracted with 1% Triton X-100 at
4 °C, and the soluble (S) and insoluble (I)
fractions were separated by discontinuous sucrose gradient
centrifugation as described under "Experimental Procedures." Tg
immunoprecipitated from these fractions was analyzed by SDS-PAGE and
autoradiography. D, Triton X-100-insoluble fractions from
FRT cells prepared as described for panel C were digested in
the absence ( ) or presence (+) of endoglycosidase H.
|
|
We then proceeded to examine polarized Tg secretion from the stably
transfected FRT cells. Surprisingly, no pulse-labeled Tg was recovered
in either the apical or basolateral medium after 4 h of chase;
instead, all labeled Tg remained cell-associated (Fig.
6A). We therefore extended our
analysis to prolonged chase times of up to 2 days. Over this period in
MDCK cells, labeled Tg converted from being quantitatively recovered in
the cell lysate at the zero chase time to near quantitatively recovered
in the culture supernatant (Fig. 6B). However, from FRT
cells over 48 h, only very little Tg (<10%) was ever recovered
in the culture supernatant. This behavior was observed in three
independently selected clones of FRT cells expressing Tg (not shown).
The fact that Tg in FRT cells progressed into a Triton X-100-insoluble fraction and acquired endoglycosidase H resistance (Fig. 5) rendered unlikely the possibility that the protein failed to undergo ER-to-Golgi transport. Moreover, unlike CHO cells (36, 40), COS cells (46), or MDCK
cells (see above), as measured by immunofluorescence microscopy of
permeabilized FRT cells, the predominant pool of recombinant Tg in the
steady state was not in the ER but exhibited primarily a perinuclear
pattern (Fig. 6C).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
Tg is not secreted from FRT cells and
accumulates in the juxtanuclear region. A, filter-grown
FRT cells stably expressing recombinant Tg were metabolically labeled
for 30 min and chased in complete medium for 4 h. Tg was
immunoprecipitated from the apical ("A") and basolateral
("B") culture media as well as the cell lysate
(Lys). The immunoprecipitates were then subjected to
SDS-PAGE and autoradiographed. B, FRT and MDCK cells (grown
in plastic dishes) were metabolically labeled for 30 min with
[35S]methionine/cysteine and then chased for up to 2 days
in complete medium. At each of the indicated chase times, Tg was
immunoprecipitated from the cell lysate (L) and culture
supernatant (S) and analyzed by SDS-PAGE and
autoradiography. C, confocal immunofluorescence analysis of
intracellular Tg in FRT cells. The cells were fixed, permeabilized, and
labeled using anti-Tg antibodies followed by fluorescent secondary
antibodies.
|
|
Interestingly, in FRT cells, caveolin-2 in the steady state fails to
localize to the plasma membrane, yielding instead a perinuclear distribution. However, after FRT cells are transfected to express caveolin-1, caveolin-2 localizes to the plasma membrane (28). This
could be taken to mean that in FRT cells, some proteins (especially those employing a caveolin-1-mediated pathway) may be impaired in
transport to the cell surface (28). We also considered that in FRT
cells, transport of Tg from the biosynthetic pathway to the plasmalemma
might occur, but Tg release at the apical cell surface might be
impaired (with Tg remaining adherent to the apical membrane or entering
the endosomal system). To begin to investigate these possibilities, we
asked if it was possible to tag Tg at the surface of FRT cells using a
nonpermeant biotinylation reagent.
Filter-grown FRT or MDCK cells expressing Tg were metabolically labeled
with 35S-labeled amino acids. After a 4-h chase, the cells
were biotinylated at either the apical or basolateral cell surfaces
before cell lysis, Tg immunoprecipitation, SDS-PAGE, and
electrotransfer. As shown in Fig.
7A (lower panel),
cell-associated 35S-Tg recovered from both sets of cells
was equivalent. Finally, the samples were blotted with
streptavidin-peroxidase to detect only surface-bound Tg. In MDCK cells,
from which Tg is freely secreted (Figs. 1 and 6), essentially no Tg
could be detected that was bound at the cell surface; however, in FRT
cells, a strong apically biotinylated Tg signal was detected (Fig.
7A, upper panel). This experiment was then modified in two
ways. First, FRT cells were labeled overnight with
35S-labeled amino acids, biotinylated either apically or
basolaterally, lysed, and immunoprecipitated with anti-Tg (Fig.
7B, first two lanes), and the immunoprecipitates were then
reprecipitated with streptavidin-agarose (Fig. 7B, last two
lanes). From this, we deduced that whereas the majority of
cell-associated Tg was indeed intracellular, ~20% of cell-associated
Tg was accessible to the biotinylation reagent at the apical
plasmalemma (Fig. 7B). (This must be considered a minimum
value, as the efficiency of cell surface biotinylation is almost
certainly less than 100% (47).) Second, we repeated exactly the
experiment of Fig. 7A, except without or with prior
cholesterol depletion. Without cholesterol depletion, the
apical:basolateral ratio of surface-tagged Tg was ~4.9, whereas after
cholesterol depletion the ratio was only ~1.2.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 7.
Tg accumulates on the apical surface of FRT
cells in GEMs/rafts. A, filter-grown FRT and MDCK cells
were metabolically labeled for 30 min with
[35S]methionine/cysteine and chased for 4 h. Cells
were then surface biotinylated from either the apical
("A") or basolateral ("B") sides and
lysed with radioimmune precipitation buffer. Tg immunoprecipitated from
the cell lysates was then analyzed either by direct autoradiography
(bottom panel) or by immunoblotting with
streptavidin-peroxidase (top panel). B, FRT cells
were labeled, chased, surface-biotinylated from either the apical or
basolateral sides, and lysed as described in panel A. Tg
immunoprecipitates from each sample were split in half. One half was
saved for direct analysis (IP -Tg), and the
second half was washed twice, eluted in the presence of boiling 1%
SDS, reconstituted in radioimmune precipitation buffer, and then
reprecipitated with streptavidin-agarose (IP St-Agar.).
Quantitation of these data indicate that at least 20% of
cell-associated Tg is accessible at the apical surface. C,
biotinylated FRT cells (grown in plastic dishes) were lysed with cold
1% Triton X-100 and centrifuged to equilibrium in a continuous sucrose
density gradient as in Fig. 2A. Tg was immunoprecipitated
from each fraction and analyzed by SDS-PAGE and blotting with
streptavidin-peroxidase. Note that all biotinylated Tg is recovered in
the GEM/raft fraction.
|
|
Next, we examined nonpermeabilized FRT or MDCK cells expressing Tg by
immunofluorescence with a polyclonal anti-Tg antibody. In
nonpermeabilized MDCK cells, Tg immunofluorescence at the cell surface
was extremely faint (Fig. 8, lower
half) and by two-dimensional z-section reconstruction
(bottom panels), most of the apical surface of MDCK cells
was free of Tg immunoreactivity. However, in nonpermeabilized FRT
cells, Tg showed a generally similar distribution to that of
dipeptidylpeptidase IV, an established apical marker of these cells,
with the majority of the apical surface positive for Tg immunofluorescence (Fig. 8, upper half). Together, the data
in Figs. 7 and 8 indicate that in FRT cells, Tg exit from the Golgi is
not blocked. Rather, apical Tg sorting appears similar to that found in
MDCK and PC Cl3 cells, although Tg externalized by FRT cells remains
adherent to the apical cell membrane. Importantly, when biotinylated
FRT cells were subsequently lysed in cold Triton X-100, all
surface-tagged Tg floated out of the load upon sucrose gradient
centrifugation and was recovered in fractions enriched in GEM/raft
microdomains (fractions 7-9, Fig. 7C). Thus, in FRT cells,
Tg enters Triton X-100-insoluble microdomains during transit through
the secretory pathway (within 60 min of biosynthesis; see Fig.
5C), thereafter appearing in GEMs/rafts at the apical cell
surface.

View larger version (100K):
[in this window]
[in a new window]
|
Fig. 8.
Confocal analysis detects apical surface
expression of Tg in nonpermeabilized FRT cells. FRT and MDCK cells
grown in filter culture inserts were fixed and labeled using anti-Tg
antibodies (panels on left). Sections in the
x-y (larger image) and
x-z (smaller image) dimensions are
shown. As a control, the surface distributions of dipeptidyl peptidase
IV and gp114, endogenous apical membrane markers of FRT and MDCK cells,
respectively, were analyzed in parallel (panels on
right).
|
|
Fate of Apically Biotinylated Tg in FRT Cells--
We then
followed the fate of surface Tg using FRT cells that were apically
biotinylated before being returned to routine cell culture. Although
there was no loss of biotinylated Tg over the first 4 h of culture
(not shown), thereafter biotinylated Tg slowly disappeared from
the cells as measured in lysates prepared over a 2-day period (Fig.
9A). Importantly, however, no
biotinylated Tg ever appeared in the culture supernatant (Fig.
9A). Instead, intracellular degradation of biotinylated Tg
over 24 h was nearly completely blocked by treatment of the cells
with 100 µM chloroquine (Fig. 9B). These data
suggested the possibility that apically bound Tg might be internalized
via the endocytic pathway and be slowly degraded in the
endosome-lysosome system. To explore this possibility, we
examined the intracellular immunofluorescent localization of Tg in FRT
cells in conjunction either with mannosidase II (an established Golgi
marker) or with EEA1 or transferrin, markers of early and recycling
endosomes, respectively. As shown in Fig. 10, Tg colocalized negligibly with the
first two markers (top panels) but showed partial overlap
with transferrin (lower panels), consistent with the idea
that some if not all Tg reaches the endosomal system in FRT cells.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 9.
Gradual degradation of surface Tg in FRT
cells is chloroquine inhibitable. FRT cells grown in plastic
dishes were surface-biotinylated and then returned to complete medium
for the indicated times. A, Tg immunoprecipitated from the
cell lysate (L) and culture supernatant (S) at
each chase time was analyzed by SDS-PAGE and blotting with
streptavidin-peroxidase. B, surface-biotinylated FRT cells
were incubated in the absence or presence of 100 mM
choroquine (Chloroq.) before Tg immunoprecipitation and
blotting with streptavidin-peroxidase.
|
|

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 10.
Immunofluorescence localization of
intracellular Tg in permeabilized FRT cells. FRT cells
expressing Tg were fixed and double-labeled using anti-Tg antibodies
(these antibodies applied first; far left panels) and with
antibodies against Golgi mannosidase II (top middle
panel), EEA1 (center panel), or transferrin
(lower middle panel; see "Experimental Procedures"). For
mannosidase II or EEAI, secondary detection employed fluorescein
isothiocyanate-conjugated antibodies, whereas transferrin was detected
with fluorescein isothiocyanate-conjugated streptavidin. Merged images
are shown in the panels on the right.
|
|
 |
DISCUSSION |
Apical targeting of Tg to the lumen of thyroid follicles is
essential for thyroid hormone synthesis (2). All studies to date
indicate that pathophysiological conditions in which Tg is either
delivered insufficiently to the follicle lumen (3) or delivered
abnormally to the basolateral surface (48, 49) are associated with
serious disorders of thyroid hormone production. To understand such
disorders, it is first necessary to begin to understand the normal
apical targeting of Tg, the mechanism(s) of which have never previously
been explored. We now demonstrate that in MDCK cells, which lack a
classical regulated secretory pathway, recombinant Tg is
secreted apically (Fig. 1); it can be recovered in the GEM/raft
fraction (Fig. 2); and its apical secretion is severely inhibited by
cellular cholesterol depletion (Fig. 3). By contrast, Tg expressed
endogenously in thyrocytes is packaged into the regulated secretory
pathway (6, 7, 50, 51). Intriguingly, endogenously expressed Tg in PC
Cl3 thyrocytes is also secreted apically and is recovered in the
GEM/raft fraction (Fig. 4). Thus, whether in MDCK cells or thyrocytes, Tg is the first secretory protein demonstrated to associate with Triton
X-100-insoluble membrane domains en route to the apical surface of epithelial cells. Superficially, the new findings in MDCK
cells would seem to cast doubt on our previous postulate that the
apical Tg targeting mechanism in thyrocytes is in some way related to,
or dependent upon, sorting to the regulated secretory pathway (9).
However, in light of very recent reports suggesting that two different
secretory proteins may enter the regulated secretory pathway as a
consequence of association with GEM/raft microdomains (25, 26), it now
appears that, for some cases, there are indeed important similarities
in the mechanisms of regulated secretory protein sorting and apical
secretory protein sorting.
In PC Cl3 cells and MDCK cells, the detection of Triton X-100-insoluble
Tg is limited to the Golgi/post-Golgi (endoglycosidase H-resistant)
form (Figs. 1 and 2). Such detergent insolubility does not occur when
the cells are lysed in octylglucoside,2 a detergent
that is known to solubilize the GEM/raft fraction. Further, because
these cell types secrete rather than store post-Golgi Tg, only a small
quantity of cellular Tg is ever recovered in Triton X-100-insoluble
fractions (Fig. 2). Once secreted into the medium, Tg is completely
soluble in cold Triton X-100.2 Thus, we conclude that in
MDCK and PC Cl3 cells, the detection of Triton X-100 insolubility
represents a transient state of the protein that takes place during its
biosynthetic transport to the plasma membrane.
Although Tg is also recovered in GEMs/rafts of FRT cells (Fig.
5A), the situation differs in two important ways. First,
most Tg becomes Triton X-100-insoluble within 60 min of chase (Fig. 5C), i.e. with a half-time that is faster than
the half-time of Golgi arrival (39), and indeed, a portion (albeit a
minority) of the Tg recovered in the GEM/raft fraction is
endoglycosidase H-sensitive (Fig. 5B). Indeed, it appears
likely (Fig. 5D) that GEM/raft assembly may begin even in
pre-Golgi or early Golgi compartments (45). Second, in a manner
different from what has been observed in primary thyrocytes (6, 52), Tg
is not effectively secreted from FRT cells into either the apical or
basolateral medium (Fig. 6A) even at very prolonged chase
times (Fig. 6B). Instead, Tg remains cell-associated and is
distributed between two predominant regions of these cells.
One portion of Tg in FRT cells is extracellularly disposed on the
apical plasma membrane (Fig. 8). Indeed, surface biotinylation of FRT
cells indicates that apically bound surface Tg represents a significant
minority of the total cellular pool (Fig. 7B). Importantly, all of this surface Tg is recovered in GEMs/rafts (Fig. 7C),
and the apical predominance is blocked by cholesterol depletion. Thus, in FRT cells, although GPI-anchored proteins are unable to enter Triton
X-100-insoluble GEMs/rafts (44), Tg is still able to do so. The
situation is quite intriguing, as the extent and affinity of Tg
association either with lipids or proteins endogenous to the GEM/raft
pathway is dramatically greater in FRT than other cell types (Fig. 5).
However, because FRT cells are not known to express any
thyroid-specific gene products, and because cultured primary thyrocytes
and PC Cl3 cells are known to secrete large quantities of Tg into the
medium (Ref. 6 and this report), we must presume until further evidence
becomes available that the absence of Tg secretion in FRT cells is
atypical and not reflective of endogenous Tg trafficking in the
secretory pathway of normal thyrocytes. A second portion of Tg in FRT
cells is located intracellularly (Fig. 6C) in a perinuclear
distribution. This seems consistent with Tg entry into the
endosome/lysosome system, as suggested by the degradation of
surface-biotinylated Tg in a chloroquine-inhibitable manner (Fig. 9).
Interestingly, Tg entry into the endosomal system in FRT cells is
reminiscent of such entry during hormonogenesis in the thyroid gland
(1, 53, 54). Much of this endosomal Tg seems to be localized with
transferrin in recycling endosomes rather than in early sorting
endosomes (Fig. 10), although other endosomal compartments may also be
involved in Tg trafficking in FRT cells. It will be of interest in
future studies to examine whether expression of caveolin-1 in FRT cells
could cause relocation of any portion of intracellular Tg from its
perinuclear distribution to the cell surface (28).
Data from each of the three epithelial cell types investigated strongly
suggest that Tg, the first documented member of what is certainly a
larger class of apical secretory proteins, is specifically recruited into membrane carriers destined for the apical surface. The
fact that newly synthesized Tg is insoluble in Triton X-100, under
conditions in which some compartments are completely solubilized and
most others are permeabilized, points strongly to the idea that Tg is
specifically bound to one or more components of GEMs/rafts. To date, we
do not know what these components are. A popular model to explain
apical-selective transport is that one or more lectins incorporated
into GEM/raft microdomains capture and deliver glycoprotein cargo (11,
14, 27, 55, 56). Although this model may be plausible for Tg, we do not
wish to argue that this represents the sole mechanism for all apical
secretory protein targeting. First, expression of at least two
regulated secretory proteins, growth hormone and parathyroid hormone
(neither of which is glycosylated), leads to apical delivery in primary
thyrocytes (9). Second, certain glycoproteins, such as the extensively
O-glycosylated human neurotrophin receptor, are
delivered apically in thyroid-derived FRT cells but are not
incorporated into the GEM/raft fraction (33). Further, apical pathways
that are independent of glycosylation (57) or GEM/raft incorporation
(58) have also been described in MDCK cells.
Thus, many possibilities for apical cargo delivery still exist.
Nevertheless, it does appear that proteins that are recruited into
GEM/raft microdomains (18) are dependent upon cellular cholesterol
levels either at the level of cargo entry or at the level of delivery
of the membrane carrier to the apical surface (41), and this is
certainly true for Tg (Fig. 3). At present, we speculate that of these
possibilities, cholesterol might be more important in the pathway of
delivery of the apical membrane carrier, because cholesterol depletion
does not appear to prevent Tg recruitment into the GEM/raft
fraction.3
Prior to this report, two apical secretory proteins, a truncated form
of alkaline phosphatase (21) and the endogenous gp80/clusterin of MDCK
cells (20), were specifically tested and not recovered in Triton
X-100-insoluble fractions. The secretory form of alkaline phosphatase
appears to exhibit identical polarized sorting to its GPI-anchored,
GEM/raft-associated counterpart in FRT cells (21). However, polarized
trafficking of the latter form is unaffected by cholesterol depletion
and instead is perturbed by FB1, an inhibitor of
glycosphingolipid synthesis (21). By contrast, we find that apical Tg
trafficking in MDCK cells is largely blocked by cellular cholesterol
depletion and is unaffected by FB1 (Fig. 3). Interestingly, apical trafficking of the endogenous gp80 glycoprotein in MDCK cells is
also largely blocked by cellular cholesterol treatment (41) and is
unaffected by FB1 (59). Thus, the lack of recovery of gp80
in GEM/raft microdomains may imply the existence of more than one kind
of cholesterol-containing apical raft in MDCK cells, consistent with
recent suggestions (60). Alternatively, the same GEM/raft pathway used
by Tg may also carry gp80, but the association is insufficiently strong
for gp80 to remain intact after Triton X-100 extraction (41).
In conclusion, we report that Tg is the first apical secretory protein
demonstrated to associate with Triton X-100-insoluble GEMs/rafts,
implying a cargo-selective process. Hopefully, these findings will
promote further investigations to define both cargo-selective as well
as possible cargo-nonselective secretory mechanisms.
 |
ACKNOWLEDGEMENT |
We thank Dr. C. Sanchez for help with the
confocal microscopy.
 |
FOOTNOTES |
*
This work was supported by grants from the National
Institutes of Health (DK40344 to P. A.), the Direccion General de
Ensenanza Superior (PM99-0092 to M. A. A.), and the Comunidad de
Madrid (08.3/0020/1998) and by an institutional grant from the
Fundacion Ramon Areces to Centro de Biologia Molecular
"Severo Ochoa."The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Recipient of a fellowship from the Comunidad de Madrid.
To whom correspondence should be addressed: Div. of
Endocrinology, Albert Einstein College of Medicine, 1300 Morris Park
Ave., Bronx NY 10461. Tel.: 718-430-8685; FAX: 718-430-8557; E-mail: arvan@aecom.yu.edu.
Published, JBC Papers in Press, September 29, 2000, DOI 10.1074/jbc.M005429200
2
F. Martin-Belmonte, M. A. Alonso,
X. Zhang, and P. Arvan, our unpublished observations.
3
F. Martin-Belmonte, M. A. Alonso,
X. Zhang, and P. Arvan, our preliminary data.
 |
ABBREVIATIONS |
The abbreviations used are:
Tg, thyroglobulin;
ER, endoplasmic reticulum;
MDCK cells, Madin-Darby canine kidney cells;
CHO cells, Chinese hamster ovary cells;
PBS, phosphate-buffered
saline;
PAGE, polyacrylamide gel electrophoresis;
GPI, glycosylphosphatidylinositol;
FB1, fumonisin B1.
 |
REFERENCES |
| 1.
|
Ekholm, R.
(1990)
Int. Rev. Cytol.
120,
243-288
|
| 2.
|
Arvan, P.,
Kim, P. S.,
Kuliawat, R.,
Prabakaran, D.,
Muresan, Z.,
Yoo, S. E.,
and Hossain, S. A.
(1997)
Thyroid
7,
89-105
|
| 3.
|
Medeiros-Neto, G.,
Targovnik, H. M.,
and Vassart, G.
(1993)
Endocr. Rev.
14,
165-183
|
| 4.
|
Kim, P. S.,
Kwon, O.-Y.,
and Arvan, P.
(1996)
J. Cell Biol.
133,
517-527
|
| 5.
|
Kuliawat, R.,
Lisanti, M. P.,
and Arvan, P.
(1995)
J. Biol. Chem.
270,
2478-2482
|
| 6.
|
Arvan, P.,
and Lee, J.
(1991)
J. Cell Biol.
112,
365-376
|
| 7.
|
Prabakaran, D.,
Kim, P. S.,
Kim, K.-R.,
and Arvan, P.
(1993)
J. Biol. Chem.
268,
9041-9048
|
| 8.
|
Desruisseau-Gonzalvez, S.,
Delori, P.,
Gruffat, D.,
and Chabaud, O.
(1993)
In Vitro Cell Dev. Biol.
29A,
161-164
|
| 9.
|
Prabakaran, D., S., A. R.,
Harney, J. W.,
Berry, M. J.,
Larsen, P. R.,
and Arvan, P.
(1999)
J. Cell Sci.
112,
1247-1256
|
| 10.
|
Caplan, M. J.,
Stow, J. L.,
Newman, A. P.,
Madri, J.,
Anderson, H. C.,
Farquhar, M. G.,
Palade, G. E.,
and Jamieson, J. D.
(1987)
Nature (Lond.)
329,
632-635
|
| 11.
|
Scheiffele, P.,
Peranen, J.,
and Simons, K.
(1995)
Nature (Lond.)
378,
96-98
|
| 12.
|
Ikonen, E.,
and Simons, K.
(1998)
Semin. Cell Dev. Biol.
9,
503-509
|
| 13.
|
Scheiffele, P.,
Roth, M. G.,
and Simons, K.
(1997)
EMBO J.
16,
5501-5508
|
| 14.
|
Yeaman, C.,
Gall, A. H. L.,
Baldwin, A. N.,
Monlauzeur, L.,
Bivic, A. L.,
and Rodriguez-Boulan, E.
(1997)
J. Cell Biol.
139,
929-940
|
| 15.
|
Gut, A.,
Kappeler, F.,
Hyka, N.,
Balda, M. S.,
Hauri, H. P.,
and Matter, K.
(1998)
EMBO J.
17,
1919-1929
|
| 16.
|
Puertollano, R.,
Martin-Belmonte, F.,
Millan, J.,
de Marco, M. C.,
Albar, J. P.,
Kremer, L.,
and Alonso, M. A.
(1999)
J. Cell Biol.
145,
141-151
|
| 17.
|
Schroeder, R. J.,
Ahmed, S. N.,
Zhu, Y.,
London, E.,
and Brown, D. A.
(1998)
J. Biol. Chem.
273,
1150-1157
|
| 18.
|
Pralle, A.,
Keller, P.,
Florin, E. L.,
Simons, K.,
and Horber, J. K.
(2000)
J. Cell Biol.
148,
997-1008
|
| 19.
|
Brown, D. A.,
and Rose, J. K.
(1992)
Cell
68,
533-544
|
| 20.
|
Graichen, R.,
Losch, A.,
Appel, D.,
and Koch-Brandt, C.
(1996)
J. Biol. Chem.
271,
15854-15857
|
| 21.
|
Lipardi, C.,
Nitsch, L.,
and Zurzolo, C.
(2000)
Mol. Biol. Cell
11,
531-542
|
| 22.
|
Arvan, P.,
and Castle, D.
(1998)
Biochem. J.
332,
593-610
|
| 23.
|
Arvan, P.,
and Castle, J. D.
(1982)
J. Cell Biol.
95,
8-19
|
| 24.
|
Cameron, R. S.,
and Castle, J. D.
(1984)
J. Membr. Biol.
79,
127-144
|
| 25.
|
Blazquez, M.,
Thiele, C.,
Huttner, W. B.,
Docherty, K.,
and Shennan, K. I.
(2000)
Biochem. J.
349,
843-852
|
| 26.
|
Dhanvantari, S.,
and Loh, Y. P.
(2000)
J. Biol. Chem.
275,
29887-29893
|
| 27.
|
Fiedler, K.,
Parton, R. G.,
Kellner, R.,
Etzold, T.,
and Simons, K.
(1994)
EMBO J.
13,
1729-1740
|
| 28.
|
Mora, R.,
Bonilha, V. L.,
Marmorstein, A.,
Scherer, P. E.,
Brown, D.,
Lisanti, M. P.,
and Rodriguez-Boulan, E.
(1999)
J. Biol. Chem.
274,
25708-25717
|
| 29.
|
Parolini, I.,
Sargiacomo, M.,
Galbiati, F.,
Rizzo, G.,
Grignani, F.,
Engelman, J. A.,
Okamoto, T.,
Ikezu, T.,
Scherer, P. E.,
Mora, R.,
Rodriguez-Boulan, E.,
Peschle, C.,
and Lisanti, M. P.
(1999)
J. Biol. Chem.
274,
25718-25725
|
| 30.
|
Puertollano, R.,
and Alonso, M. A.
(1999)
Mol. Biol. Cell
10,
3435-3447
|
| 31.
|
Cheong, K. H.,
Zacchetti, D.,
Schneeberger, E. E.,
and Simons, K.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
6241-6248
|
| 32.
|
Arvan, P.,
and Castle, J. D.
(1987)
J. Cell Biol.
104,
243-252
|
| 33.
|
Lipardi, C.,
Nitsch, L.,
and Zurzolo, C.
(1999)
Biochimie (Paris)
81,
347-353
|
| 34.
|
Tarutani, O.,
Kondo, T.,
and Shulman, S.
(1977)
Biochim. Biophys. Acta
492,
284-299
|
| 35.
|
Formisano, S.,
Di Jeso, B.,
Acquaviva, R.,
Consiglio, E.,
and Palumbo, G.
(1983)
Arch. Biochem. Biophys.
227,
351-357
|
| 36.
|
Muresan, Z.,
and Arvan, P.
(1997)
J. Biol. Chem.
272,
26095-26102
|
| 37.
|
Balcarova-Stander, J.,
Pfeiffer, S. E.,
Fuller, S. D.,
and Simons, K.
(1984)
EMBO J.
3,
2687-2694
|
| 38.
|
Petell, J. K., A., Q.,
Hong, W. J.,
Hixson, D. C.,
Amarri, S.,
Reif, S.,
and Bujanover, Y.
(1990)
Exp. Cell Res.
187,
299-308
|
| 39.
|
Kim, P. S.,
and Arvan, P.
(1993)
J. Biol. Chem.
268,
4873-4879
|
| 40.
|
Muresan, Z.,
and Arvan, P.
(1998)
Mol. Endocrinol.
12,
458-467
|
| 41.
|
Keller, P.,
and Simons, K.
(1998)
J. Cell Biol.
140,
1357-1367
|
| 42.
|
Zurzolo, C.,
Polistina, C.,
Saini, M.,
Gentile, R.,
Aloj, L.,
Migliaccio, G.,
Bonatti, S.,
and Nitsch, L.
(1992)
J. Cell Biol.
117,
551-564
|
| 43.
|
Zurzolo, C.,
Lisanti, M. P.,
Caras, I. W.,
Nitsch, L.,
and Rodriguez-Boulan, E.
(1993)
J. Cell Biol.
121,
1031-1039
|
| 44.
|
Zurzolo, C.,
van't Hof, W.,
van Meer, G.,
and Rodriguez-Boulan, E.
(1994)
EMBO J.
13,
42-53
|
| 45.
|
Muniz, M.,
and Riezman, H.
(2000)
EMBO J.
19,
10-15
|
| 46.
|
Kim, P. S.,
Hossain, S. A.,
Park, Y.-N.,
Lee, I.,
Yoo, S.-E.,
and Arvan, P.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9909-9913
|
| 47.
|
Zhang, X.,
and Arvan, P.
(2000)
J. Biol. Chem.
275,
31946-31953
|
| 48.
|
Marino, M.,
Zheng, G.,
Chiovato, L.,
Pinchera, A.,
Brown, D.,
Andrews, D.,
and McCluskey, R. T.
(2000)
J. Biol. Chem.
275,
7125-7137
|
| 49.
|
Marino, M.,
and McCluskey, R. T.
(2000)
Thyroid
10,
461-469
|
| 50.
|
Bjorkman, U.,
Ekholm, R.,
and Ericson, L. E.
(1978)
Endocrinology
102,
460-470
|
| 51.
|
Chambard, M.,
Depetris, D.,
Gruffat, D.,
Gonzalvez, J.,
Mauchamp, J.,
and Chabaud, O.
(1990)
J. Mol. Endocrinol.
4,
193-199
|
| 52.
|
Kim, P. S.,
and Arvan, P.
(1991)
J. Biol. Chem.
266,
12412-12418
|
| 53.
|
Herzog, V.
(1984)
Int. Rev. Cytol.
91,
107-139
|
| 54.
|
Kostrouch, Z.,
Munari-Silem, Y.,
Rajas, F.,
Bernier-Valentin, F.,
and Rousset, B.
(1991)
Endocrinology
129,
2202-2211
|
| 55.
|
Alfalah, M.,
Jacob, R.,
Preuss, U.,
Zimmer, K. P.,
Naim, H.,
and Naim, H. Y.
(1999)
Curr. Biol.
9,
593-596
|
| 56.
|
Benting, J. H.,
Rietveld, A. G.,
and Simons, K.
(1999)
J. Cell Biol.
146,
313-320
|
| 57.
|
Marzolo, M. P.,
Bull, P.,
and Gonzalez, A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
1834-1839
|
| 58.
|
Alonso, M. A.,
Fan, L.,
and Alarcon, B.
(1997)
J. Biol. Chem.
272,
30748-30752
|
| 59.
|
Mays, R. W.,
Siemers, K. A.,
Fritz, B. A.,
Lowe, A. W.,
van Meer, G.,
and Nelson, W. J.
(1995)
J. Cell Biol.
130,
1105-1115
|
| 60.
|
Roper, K.,
Corbeil, D.,
and Huttner, W. B.
(2000)
Nat. Cell Biol.
2,
582-592
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E Robin, J Cognie, F Foulon-Gauze, J Fontaine, and X Cayla
Disruption of Lipid Rafts Induces Gonadotropin Release in Ovine Pituitary and LbetaT2 Gonadotroph Cells
Biol Reprod,
July 1, 2008;
79(1):
17 - 25.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Ramnarayanan, C. A. Cheng, M. Bastaki, and P. L. Tuma
Exogenous MAL Reroutes Selected Hepatic Apical Proteins into the Direct Pathway in WIF-B Cells
Mol. Biol. Cell,
July 1, 2007;
18(7):
2707 - 2715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Sobota, F. Ferraro, N. Back, B. A. Eipper, and R. E. Mains
Not All Secretory Granules Are Created Equal: Partitioning of Soluble Content Proteins
Mol. Biol. Cell,
December 1, 2006;
17(12):
5038 - 5052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Lara-Lemus, M. Liu, M. D. Turner, P. Scherer, G. Stenbeck, P. Iyengar, and P. Arvan
Lumenal protein sorting to the constitutive secretory pathway of a regulated secretory cell
J. Cell Sci.,
May 1, 2006;
119(9):
1833 - 1842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ramos-Castaneda, Y.-n. Park, M. Liu, K. Hauser, H. Rudolph, G. E. Shull, M. F. Jonkman, K. Mori, S. Ikeda, H. Ogawa, et al.
Deficiency of ATP2C1, a Golgi Ion Pump, Induces Secretory Pathway Defects in Endoplasmic Reticulum (ER)-associated Degradation and Sensitivity to ER Stress
J. Biol. Chem.,
March 11, 2005;
280(10):
9467 - 9473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Laughlin, G. C. McGugan, R. R. Powell, B. H. Welter, and L. A. Temesvari
Involvement of Raft-Like Plasma Membrane Domains of Entamoeba histolytica in Pinocytosis and Adhesion
Infect. Immun.,
September 1, 2004;
72(9):
5349 - 5357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Costa, Y. Song, P. Macours, C. Massart, M. C. Many, S. Costagliola, J. E. Dumont, J. Van Sande, and V. Vanvooren
Sphingolipid-Cholesterol Domains (Lipid Rafts) in Normal Human and Dog Thyroid Follicular Cells Are Not Involved in Thyrotropin Receptor Signaling
Endocrinology,
March 1, 2004;
145(3):
1464 - 1472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Lisman, T. Pomorski, C. Vogelzangs, D. Urli-Stam, W. de Cocq van Delwijnen, and J. C. M. Holthuis
Protein Sorting in the Late Golgi of Saccharomyces cerevisiae Does Not Require Mannosylated Sphingolipids
J. Biol. Chem.,
January 9, 2004;
279(2):
1020 - 1029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Walmsley, F. Zeng, and N. M. Hooper
The N-terminal Region of the Prion Protein Ectodomain Contains a Lipid Raft Targeting Determinant
J. Biol. Chem.,
September 26, 2003;
278(39):
37241 - 37248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Feng and P. Arvan
The Trafficking of {alpha}1-Antitrypsin, a Post-Golgi Secretory Pathway Marker, in INS-1 Pancreatic Beta Cells
J. Biol. Chem.,
August 22, 2003;
278(34):
31486 - 31494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. K. Vogel, S. Sahkri, H. Sjostrom, O. Noren, and M. Spiess
Secretion of Antithrombin Is Converted from Nonpolarized to Apical by Exchanging Its Amino Terminus for That of Apically Secreted Family Members
J. Biol. Chem.,
April 12, 2002;
277(16):
13883 - 13888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zheng and J. E. Sadler
Mucin-like Domain of Enteropeptidase Directs Apical Targeting in Madin-Darby Canine Kidney Cells
J. Biol. Chem.,
February 22, 2002;
277(9):
6858 - 6863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Martin-Belmonte, P. Arvan, and M. A. Alonso
MAL Mediates Apical Transport of Secretory Proteins in Polarized Epithelial Madin-Darby Canine Kidney Cells
J. Biol. Chem.,
December 21, 2001;
276(52):
49337 - 49342.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|